Clinical characteristics and mortality of patients with hematologic malignancies and COVID-19: a systematic review [PDF]
, 2020 Objective: Hematologic cancer patients with Coronavirus Disease 2019 (COVID-19) tend to have a more serious disease course than observed in the general population.
이금화 +14 more
core +4 more sources
COVID-19 Severity and Survival over Time in Patients with Hematologic Malignancies: A Population-Based Registry Study [PDF]
, 2023 Mortality rates for COVID-19 have declined over time in the general population, but data in patients with hematologic malignancies are contradictory. We identified independent prognostic factors for COVID-19 severity and survival in unvaccinated patients
Martos Martinez, Rafael +138 more
core +1 more source
Advances in Hematologic Malignancies [PDF]
, 2019 The book Advances in Hematologic Malignancies presents new knowledge of cellular disease processes, molecular pathology, and cytogenetic, epigenetic, and genomic changes that have influenced the current outlook toward hematological malignancies.
core +1 more source
1q triplication in hematologic malignancies [PDF]
, 2010 Review on 1q triplication in hematologic malignancies, with data on clinics, and the genes ...
Park, TS, Choi, JR, JR Choi, TS Park
core +1 more source
Immune Therapies for Hematologic Malignancies
, 2021 The era of immunotherapy for hematologic malignancies began with the first allogeneic hematopoietic stem cell transplant (HSCT) study published by E [...
Matthew J. Olnes
core +1 more source
Imaging Musculoskeletal Manifestations of Pediatric Hematologic Malignancies
, 2021 OBJECTIVE. The purpose of this article is to describe imaging findings of common and uncommon musculoskeletal manifestations, posttreatment changes, and complications of pediatric hematologic malignancies. CONCLUSION.
Cohen, Sara +5 more
core +1 more source
GENETIC PREDISPOSITION TO HEMATOLOGIC MALIGNANCIES IN CHILDHOOD AND ADOLESCENCE [PDF]
, 2023 Advances in molecular biology and genetic testing have greatly improved our understanding of the genetic basis of hematologic malignancies and have enabled the identification of new cancer predisposition syndromes.
Francesco Fabozzi +4 more
core +1 more source
Survivorship care provision for patients with hematologic malignancies: The quest for quality evidence [PDF]
, 2015 This is an editorial that depicts the importance for developing more quality evidence to guide the survivorship care provision for patients with hematologic malignancies.\ud \ud Treatments for hematologic malignancies are often complex and debilitating ...
Chan, Alexandre, Chan, Raymond Javan
core +1 more source
mTOR regulation of metabolism in hematologic malignancies [PDF]
, 2020 Neoplastic cells rewire their metabolism, acquiring a selective advantage over normal cells and a protection from therapeutic agents. The mammalian Target of Rapamycin (mTOR) is a serine/threonine kinase involved in a variety of cellular activities ...
Simone Mirabilii +2 more
core +1 more source
Germ cell tumors and associated hematologic malignancies evolve from a common shared precursor [PDF]
, 2020 Germ cell tumors (GCTs) are the most common cancer in men between the ages of 15 and 40. Although most patients are cured, those with disease arising in the mediastinum have distinctly poor outcomes.
Tamari, Roni +53 more
core +1 more source